leftspacer middlespacer rightspacer
i
Media Menu
Featured Material


MAPS BULLETIN
MAPS Bulletin Winter 2013: 2013 Annual Report
 
Media > Ibogaine
October 3, 2008

ibogaine_news_id1378

Principal investigator John Harrison, PsyD candidate at the California Institute of Integral Studies (CIIS), received a letter from the Human Research Review Committee of CIIS granting final approval for the MAPS-sponsored ibogaine outcome protocol. John can now start our investigation into the short and longer-term outcomes of ibogaine treatment for opiate addiction.



The study will follow 30 patients who undergo ibogaine therapy at the Pangea Biomedics Ibogaine Association in Playas De Tijuana, Mexico for one year after their treatment.

  In order to gather quantitative data about outcome, John will administer the Addiction Severity Index (ASI) on a monthly basis to each subject during an approximately one-hour phone conversation. Interviews with significant others will also be conducted, as a way to try to verify the accuracy of subject self-reports. Valerie Mojeiko, MAPS Director of Operations and Clinical Research, met with John Harrison to conduct a study initiation visit on October 9.



Back to Ibogaine Research

Give Our Veterans Hope
1 in 7 Iraq and Afghanistan veterans suffer from PTSD, in many cases leading to suicide. We owe it to our veterans to stop this epidemic.

Tell the Pentagon to fund MAPS' groundbreaking work to treat PTSD.